COVID-19, SARS-CoV-2, vaccination, booster, antibody, immunity
COVID-19, SARS-CoV-2, vaccination, fractional dose, half-dose, booster, BNT162b2
pneumococcal conjugate vaccine, PCV13, vaccine-type carriage, indirect effects, Coverage, Papua New Guinea
Pneumococcal conjugate vaccine (PCV13), Pneumococcal carriage, Vaccine effectiveness, Indirect effects, Papua New Guinea